Suppository Packaging Market

Suppository Packaging Market

The global suppository packaging market is valued at USD 312 million in 2024 and is projected to reach USD 428 million by 2029, growing at 6.5% cagr from 2024 to 2029. The suppository packaging market is projected to grow significantly in the coming years. Suppository packaging is the protective packaging designed to accommodate suppositories, that are solid dosage forms in the shape of a bullet for administration through body cavities, including rectal, vaginal, or urethral. The packaging provide adequate protection to the suppository in terms of its stability and intactness right up to the time of use. The packaging material commonly selected is for their ability to maintain barrier and protection from factors such as moisture, light, oxygen, etc. The common materials used to make suppository packaging are aluminum foil, polyethylene or PE, and polyvinyl chloride or PVC and their possible combination is aluminum/PE.

Global Suppository Packaging Market Trend

To know about the assumptions considered for the study, Request for Free Sample Report

Suppository packaging Market Dynamics

Driver: Increasing demand for child-resistant packaging

The increasing demand for child-resitant packaging solutions is growing the market due to the increasing concern for safety and changing regulatory requirements. Parents and caregivers are becoming more conscious of the fact that children are prone to ingest pills accidentally and child-resistant packaging acts as a barrier to such incidences. Government regulatory agencies require such safety features for drugs, including suppositories, to minimize accidental poisonings. Also, the organization realizes that putting into practice child-resistant packaging to consumers demonstrates extra reliability and improves the brand image of their products appealing to safety-conscious consumers. Thus, besides meeting the requirements of legal standards, this demand for better safety also serves for market distinction, thereby contributing to the increasing development of suppository packaging market.

Restraint: Adherance to regulatory standards

The market offers several restrains, including strict compliance with regulatory standards, because this makes the cost of suppository packaging higher in terms of complexity, and in terms of resources needed for compliance. Adhering to strict standards entails a heavy capital outlay towards complex materials, technology, and testing leading to higher production costs that may eventually translate to higher prices. The variation in the different regulatory standards applied across the different markets also adds to the difficulty in compliance which requires packaged solutions for the different markets. This complexity can lead to extended production times and late introduction of products into the market. Further on, these standards can be challenging for small companies to implement since it takes resources, and this in turn make their margin reduced and in some case less profitable.

Opportunity: Growing demand for sustainable and environmentally friendly packaging solutions

The rising trend of sustainable packaging and environment friendly packaging is a major opportunity that lies in suppository packaging market. Consumers are becoming more aware of environmental degradation and insist on consuming products that are in protective packaging of environmental consciousness. The change of consumers’ preferences can influence the design of suppository packages created from biodegradable, recyclable, and compostable materials in compliance with the global tendencies. There are also the economic benefits of implementing sustainable packaging: the consistently increasing demand of green consumers and the growing stringency of environmental regulations, which could lead to severe penalties for companies, aid the decision to switch to sustainable packaging. Moreover, sustainable packaging may help decrease the environmental impact of the pharmaceutical business, thus enhancing its CSR activity and increasing consumers’ perception. The shift to sustainable packaging can also diversify the markets available for suppository products and innovate partnerships with other related environment-conscious organizations or firms.

Challenges: Storage and handling requirements

Suppositories usually are expected to be stored at particular temperatures that help them to maintain their shape and functionality. That can be challenging of their storage and even transport since it requires refrigeration to avoid melting. This necessitates usage of refrigeration or controlled temperature hence making the product expensive and restricting outlet choices. Suppositories are very delicate in nature and can easily get spoiled if handled inappropriately. It must offer protection from physical damaging incidences during handling and transit which may mean using a more rigid and at times expensive packaging material. Ensuring the sterility of suppositories basically depends on a well-coordinated and well-monitored supply chain. Even a small breach in the cold chain or handling of the product can result in contamination, losses, and disruption of supply chain. Labelling has to be clear, and the packaging has to facilitate usage and storage with great challenges while avoiding extra layers of complication or increased expense.

Suppository Packaging Market Ecosystem

“By material, aluminum/PE is the second fastest in the suppository packaging market, in 2023.”

Aluminium and polyethylene (PE) combined suppository packagings are a highly efficient and multi-purpose packagings for pharmaceutical products. This packaging has a layer of polyethylene that gives it the moisture barrier and light exclusion abilities and a layer of aluminum foil on top. The combination of aluminum/PE structure provides physical barrier against various influences including moisture, light and contaminants hence maintaining the suppositories’ quality and efficacy till use. This packaging type is good for the flexible, tear, and suitable for temperature suppository. It is also chemically inactive which makes it safe for products within it with no chances of coming into physical or chemical contact.

“By application, ear segment is the second fastest growing application in the suppository packaging market, in 2023.”

High prevalence of ear conditions such as infections and tinnitus is boosting the demand for efficient treatment options in turn necessitating novel forms like ear suppositories that provide directed drug delivering without being intrusive. Recent developments in drug delivery have improved the efficiency and convenience of ear suppositories, resulting major demand gains. Moreover, advancements in packaging technologies including tamper-evident and child-resistant attributes have contributed to enhancing the safety and convenience of ear suppositories for their application which is likely to contribute significantly towards growth. The rising penetration and acceptance of ear suppositories with healthcare professionals as well patient population have supported their adoption in clinical practice, thereby driving the growth. Such facets together are contributing towards the massive growth of ear suppository packaging which has emerged as the fastest-growing segment in this industry.

“Asia Pacific accounted for the fastest growing market share in the suppository packaging market, in terms of value.”

The Asia-Pacific is distinguished by a rapidly expanding population, particularly in countries like China and India, which will raise the demand for effective healthcare solutions, including suppositories. The demographic trend of an aging population is also present, necessitating the need of other methods for supplying drugs due to inability to swallow pills. Supositories and other pharmaceutical items are becoming more and more popular due to improvements in healthcare infrastructure and easier access to clinical services and products. The demand for suppository formulations is further fueled by the area's growing prevalence of chronic illnesses that need localized treatments.

To know about the assumptions considered for the study, download the pdf brochure

Suppository Packaging Market Players

Some of the key players operating in the suppository packaging market include NextPharma Technologies (UK), CordenPharma (Switzerland), Recipharm AB (Sweden), Valmatic S.R.L. (Italy), Sarong S.p.A. (Italy), Key International (US), HySum Europe GmbH (Germany), FAMAR Health Care Services (Greece), Hudi Pharma HQ (Italy), Adragos Pharma (Germany), LGM Pharma (US), Aluberg s.p.a. (Italy), Delpharm (France), Unither (France), and Trefoil Packaging Pvt Ltd (India) among others.

These companies have adopted various organic as well as inorganic growth strategies between 2019 and 2024 to strengthen their positions in the market. The new product launch is the key growth strategy adopted by these leading players to enhance regional presence and develop product portfolios to meet the growing demand for suppository packaging from emerging economies.

Suppository Packaging Scope:

This report categorizes the global suppository packaging market based on material, application, and region.

Based on the material:

• Alu/PE
• PVC/PE
• Others

Based on the application:

• Nasal
• Ear
• Rectal
• Urethral
• Vaginal
• Others (Occulary, Transdermal)

Based on the region:

• Asia Pacific
• Europe
• North America
• South America
• Middle East & Africa

Recent Developments

• In February 2022, CordenPharma completed the acquisition of three manufacturing facilities from Vifor Pharma, to be renamed CordenPharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and CordenPharma Lisbon S.A. in Portugal. The acquisition increased CordenPharma's production capacity for non-sterile drug product dosage forms, including tablets and capsules that are part of the oral solid dose (OSD) form. Suppositories, suspensions, enemas, and ear drops are all exclusively made at the Ettingen location.
• In March 2023, Adragos Pharma has acquired the Sanofi production site in Kawagoe, Japan, marking a significant expansion for the German contract development and manufacturing organization (CDMO). This acquisition positions Adragos as the third-largest pure-play CDMO in the Japanese market. The Kawagoe facility, one of Japan's largest and most advanced manufacturing sites, specializes in producing oral solids and sterile liquids, as well as providing packaging and quality control services for the Japanese and Asian markets.
• In April 2024, Delpharm has expanded its presence in the Netherlands by acquiring state-of-the-art drug production facilities from Astellas. This expansion helps Delpharm to enhance its capabilities and expand its service offerings to provide comprehensive solutions to its customers in the pharmaceutical industry.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst